Mechanisms of virus induced exacerbations of asthma

Thorax

Volumn 52, Issue 4, 1997, Pages 380-389

  Corne, Jonathan M ^a   Holgate, Stephen T ^a  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR; CYTOKINE; IMMUNOGLOBULIN E; TACHYKININ;

ASTHMA; BRONCHUS HYPERREACTIVITY; CHOLINERGIC NERVE; HUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; VIRUS INFECTION;

EID: 0030961265     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.52.4.380     Document Type: Review

References (129)

1. Djukanovic R, Roche WR, Wilson JW, Beasley CRW, Twentyman OP, Howarth PH, et al. Mucosal inflammation in asthma. Am Rev Respir Dis 1990;142: 434-57.
2. Storr J, Lenney W. School holidays and admissions with asthma. Arch Dis Child 1989;64:103-7.
3. Minor TE, Dick EC, De Meo AN, Ouellette JJ, Cohen M, Reed CE. Viruses as precipitants of asthmatic attacks in children. JAMA 1974;227:292-8.
4. Johnston S, Pattemore P, Sanderson G, Smith S, Lampe F, Josephs L, et al. Community study of the role of viral infections in exacerbations of asthma in 9-11 year old children. BMJ 1995;310:1225-9.
5. Kent J, Ireland D, Nicholson K. Respiratory viruses and exacerbations of asthma in adults. BMJ 1993;307:982-6.
6. Johnston SL, Bardin PG, Pattemore PK. Viruses as precipitants of asthma symptoms. III. Rhinoviruses: molecular biology and prospects for future intervention. Clin Exp Allergy 1993;23:237-46.
7. Empey DW, Laitnen LA, Jacobs L, Gold WM, Nadel JA. Mechanisms of bronchial hyperreactivity in normal subjects after upper respiratory tract infection. Am Rev Respir Dis 1976;113:131-9.
8. Hudgel DW, Langston L, Selner J, McIntosh K. Viral and bacterial infections in adults with chronic asthma. Am Rev Respir Dis 1979;120:393.
9. Laitinen LA, Elkin RB, Empey DW, Jacobs L, Mills J, Nadel JA. Bronchial hyperresponsiveness in normal subjects during attenuated influenza virus infection. Am Rev Respir Dis 1991;143:358-61.
10. Laitinen L, Kava T. Bronchial reactivity following uncomplicated influenza A infection in healthy subjects and asthmatic patients. Eur J Respir Dis 1980;106:51-8.
11. Little JW, Hall WJ, Douglas Jr G, Mudholkur GJ, Speers DM, Patel K. Airway hyperreactivity and peripheral airway dysfunction in Influenza A infection. Am Rev Respir Dis 1978;118:295-303.
12. Anand SC, Itkin IH, Kind LS. Effect of influenza vaccine on metacholine sensitivity in patients with asthma of known and unknown origin. J Allergy 1968;42:187.
13. Ouellete JJ, Reed CE. Increased response of asthmatic subjects to metacholine after influenza vaccine. J Allergy 1965;36:558.
14. Cheung D, Dick E, Timmers M, de Klerk E, Spaan W, Sterk P. Rhinovirus inhalation causes long lasting excessive airways narrowing in response to methacholine in asymptomatic subjects in vivo. Am J Respir Crit Care Med 1995;152:1490-6.
15. Calhoun WJ, Swanson CA, Dick EC, Schwartz LB, Lemanske RFJ, Busse WG. Experimental rhinovirus 16 infection potentiates histamine release after antigen bronchoprovocation in allergic subjects. Am Rev Respir Dis 1991;144:1267-73.
16. Henderson FW, Hu S-C, Collier AM. Pathogenesis of respiratory syncitial virus infection in ferret and fetal human tracheas in organ culture. Am Rev Respir Dis 1978; 118:29-37.
17. Ramphael R, Fischlschweiger W, Shands JW, Small Parker Jr A. Murine influenzal tracheitis: A model for the study of influenza and tracheal epithelial repair. Am Rev Respir Dis 1979;120:1313-24.
18. Richardson JB, DeNotaris A, Fergusson CC, Boucher RC. Effects of viral laryngotracheitis on the epithelial barrier of chicken airways. Lab Invest 1981;44:144-50.
19. Riedel F, Krause A, Slenczka W, Rieger C. Parainfluenza-3-virus infection enhances allergic sensitization in the guinea-pig. Clin Exp Allergy 1996;26:603-9.
20. Castleman W. Alteration in pulmonary ultrastructure and morphometric parameters induced by parainfluenza (Sendai ) virus in rats during postnatal growth. Am J Pathol 1984;114:322-35.
21. Castleman W. Respiratory tract lesions in weanling outbred rats infected with Sendai virus. Am J Vet Res 1983;44: 1025-32.
22. Walsh JJ, Dietlein LF, Low FN, Bunch GE, Mogabgab WD. Bronchotracheal response in human influenza. Arch Intern Med 1961;108:376.
23. Camner P, Jarstrand C, Philipson K. Tracheobronchial clearance in patients with influenza. Am Rev Respir Dis 1973;108:131-5.
24. Sasaki Y, Togo Y, Wagner H, Hornicak R, Swartz A, Proctor D. Mucociliary function during experimentally induced rhinovirus infection in man. Ann Otolaryngol 1973;82:203-11.
25. Szentivanyi A. The beta-adrenergic theory of atopic abnormality in asthma. J Allergy 1968;42:203-23.
26. Buckner CK, Clayton DE, Ain-Shoka AA, Busse WW, Dick EC, Shult P. Parainfluenza 3 infection blocks the ability of a beta-adrenergic receptor agonist to inhibit antigen-induced contraction of guinae pig isolated airway smooth muscle. J Clin Invest 1981;67:376-84.
27. Scarpace PJ, Bender BS. Viral pneumonia attenuates adenylate cyclase but not beta adrenergic receptors in murine lung. Am Rev Respir Dis 1989;140:1602-6.
28. Busse WW. Decreased granulocyte response to isoproterenol in asthma during upper respiratory tract infection. Am Rev Respir Dis 1977;115:783-91.
29. Buckner C, Songsiridej V, Dick E, Busse W. In vivo and in vitro studies on the use of the guinea pig as a model for virus-provoked airway hyperreactivity. Am Rev Respir Dis 1985;132:305-10.
30. Fryer A, Jacoby D. Parainfluenza virus infection damages inhibitory M2 muscarinic receptors on pulmonary parasympathetic nerves in the guinea pig. Br J Pharmacol 1991;102:267-71.
31. Fryer A, El-Fakahany E, Jacoby D. Parainfluenza virus type 1 reduces the affinity of agonists for muscarinic receptors in guinea-pig lung and heart. Eur J Pharmacol 1990;181:51-8.
32. Fryer A, Yarkony K, Jacoby D. The effect of leukocyte depletion on pulmonary M2 muscarinic receptor function in parainfluenza virus infected guinea pigs. Br J Pharmacol 1994;112:588-94.
33. Sorkness R, Clough JJ, Castleman WL, Lemanske RJ. Virus-induced airway obstruction and parasympathetic hyperresponsiveness in adult rats. Am J Respir Crit Care Med 1994;150:28-34.
34. Barnes P. Modulation of neurotransmission in the airways. Physiol Rev 1992;72:699-729.
35. Tanaka D, Grunstein M. Mechanisms of substance P-induced contraction of rabbit airway smooth muscle. J Appl Physiol 1984;57:1551-7.
36. Barnes P, Baraniuk J, Belvisi M. Neuropeptides in the respiratory tract. Part 1. Am Rev Respir Dis 1991;144: 1187-98.
37. Barnes P, Baraniuk J, Belvisi M. Neuropeptides in the respiratory tract. Part II. Am Rev Respir Dis 1991;144: 1391-9.
38. Dusser D, Jacoby D, Djokic T, Rubinstein I, Borson D, Nadel J. Virus induces airway hyperresponsiveness to tachykinins: role of neutral endopeptidase. J Appl Physiol 1989;67:1504-11.
39. Yamawaki I, Geppetti P, Bertrand C, Chan B, Massion P, Piediminte G, et al. Viral infection potentiates the increase in airway blood flow produced by substance P. J Appl Physiol 1995;79:398-404.
40. Jacoby D, Tamaoki J, Borson D, Nadel J. Influenza infection causes airway hyperresponsiveness by decreasing enkephalinase. J Appl Physiol 1988;64:2653-8.
41. Borson D, Brokaw J, Sekizawa K, McDonald D, Nadel J. Neutral endopeptidase and neurogenic inflammation in rats with respiratory infections. J Appl Physiol 1989;66: 2653-8.
42. Calhoun W, Dick E, Schwartz L, Busse W. A common cold virus, rhinovirus 16, potentiates airway inflammation after segmental antigen bronchoprovocation in allergic subjects. J Clin Invest 1994;94:2200-8.
43. Fraenkel D, Bardin P, Sanderson G, Lampe F, Johnston S, Holgate S. Lower airways inflammation during rhinovirus colds in normal and asthmatic subjects. Am Rev Respir Dis 1995;151:879-86.
44. Trigg C, Nicholson K, Wang J, Ireland D, Jordan S, Duddle J, et al. Bronchial inflammation and the common cold: a comparison of atopic and non-atopic individuals. Clin Exp Allergy 1996;26:665-78.
45. Teran L, Johnston S, Shute J, Church M, Holgate S. Increased levels of Interleukin-8 in the nasal aspirates of children with viral associated asthma. J Allergy Clin Immunol 1994;93:272.
46. Cheung D, Hiemstra PS, Dick EC, de Klerk EPA, Sterk PJ. Effects of experimental rhinovirus infection on IL-8 in nasal washings in asthmatic subjects in vivo. Eur Respir J 1994;7:481s.
47. Lau L, Corne J, Scott S, Davies R, Friend E, Howarth P. Nasal cytokines in the common cold. Am J Respir Crit Care Med 1996;153:A697.
48. Staunton D, Merluzzi V, Rothlein R, Barton R, Marlin S, Springer T. A cell adhesion molecule, ICAM-1, is the major surface receptor for rhinoviruses. Cell 1989;56: 849-53.
49. Greve JM, Davis L, Meyer AM, Forte CP, Yost S, Marlow CW, et al. The major human rhinovirus receptor is ICAM 1. Cell 1989;56:839-47.
50. Papi A, Wilson S, Johnston S. Rhinoviruses increase production of cell adhesion molecules (CAM) and NF-κB. Am J Respir Crit Care Med 1996;153:A866.
51. Johnston S, Pattemore P, Lampe F, Holgate S. The role of asthma and atopy in the suceptibility to respiratory viral infection in children. Am J Respir Crit Care Med 1994;149:A50.
52. Noah TL, Becker S. Respiratory syncytial virus-induced cytokine production by a human bronchial epithelial cell line. Am J Physiol 1993;265:L472-8.
53. Becker S, Koren H, Henke D. Interleukin-8 expression in normal nasal epithelium and its modulation by infection with respiratory syncytial virus and cytokines tumor necrosis factor, interleukin-1, and interleukin-6. Am J Respir Cell Mol Biol 1993;8:20-7.
54. Elias J, Zheng T, Einarsson O, Landry M, Trow T, Rebert N, et al. Epithelial interleukin-11: regulation by cytokines, respiratory syncytial virus and retinoic acid. J Biol Chem 1994;269:22261-8.
55. Siddiqi A, Peeples M, Brees B, Moy J. Respiratory syncytial virus-induced release of RANTES and MIP-1 by bronchial epithelial and peripheral mononuclear cells. J Allergy Clin Immunol 1996;37:305.
56. Subauste M, Jacoby D, Richards S, Proud D. Infection of a human respiratory epithelial cell line with rhinovirus. J Clin Invest 1995;96:549-57.
57. Einarsson O, Geba G, Zhu Z, Landry M, Elias J. Interleukin-11: stimulation in vivo and in vitro by respiratory viruses and induction of airway hyperresponsiveness. J Clin Invest 1996;97:915-24.
58. Zhu Z, Tang W, Ray A, Wu Y, Einarsson O, Landry M, et al. Rhinovirus stimulation of interleukin-6 in vivo and in vitro. J Clin Invest 1996;97:421-30.
59. Fahy J, Kim K, Liu J, Boushey H. Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation. J Allergy Clin Immunol 1995;95:843-52.
60. Villar M, Douglass J, Shute J, Church M, Holgate S. Interleukin-8 is a chemoattractant for eosinophils primed with interleukin-4. Am Rev Respir Dis 1993;147:A242.
61. Akira S, Taga T, Kishimoto T. Interleukin-6 in biology and medicine. Adv Immunol 1993;54:1-78.
62. DiCosmo B, Geba G, Picarella D, Elias J, Rankin A, Stripp B, et al. Airway epithelial cell expression of interleukin-6 in transgenic mice. Uncoupling of airway inflammation and bronchial hyperreactivity. J Clin Invest 1994;94:2028-35.
63. Ramsay A, Husband A, Ramshaw I, Bao S, Matthaei G, Koehler G, et al. The role of interleukin-6 in mucosal IgA antibody responses in vivo. Science 1994;264:561-3.
64. Olszewska B, Mei F, Ogra P, Garofalo R. Respiratory syncytial virus (RSV)-infected airway epithelial cells induce transendothelial migration of human blood eosinophils. J Allergy Clin Immunol 1996;97:283.
65. Hamid Q, Springall D, Riveros-Moreno V, Chanez P, Howarth P, Redington A, et al. Induction of nitric oxide synthase in asthma. Lancet 1993;342:1510-3.
66. Kharitonov S, Yates D, Springall D, Buttery L, Polak J, Robbins R, et al. Exhaled nitric oxide is increased in asthma. Chest 1995;107:156-7s.
67. Croen K. Evidence for an antiviral effect of nitric oxide. J Clin Invest 1993;91:2446-52.
68. Karupiah G, Xie Q, Buller M, Nathan C, Duarte C, MacMicking J. Inhibition of viral replication by interferon gamma induced nitric oxide synthase. Science 1993;261: 1445-8.
69. Lowenstein C, Hill S, Laford-Walker A, Wu J, Allen G, Landevere M, et al. Nitric oxide inhibits viral replication in murine myocarditis. J Clin Invest 1996;97:1837-43.
70. Gaston B, Drazen J, Loscalzo J, Stamler J. The biology of nitrogen oxides in the airways. Am J Respir Crit Care Med 1994;149:538-51.
71. Taylor-Robinson A, Liew F, Severn A, Xu D, McSorley S, Garside P, et al. Regulation of Th2 immune response by NO differentially produced by T helper type 1 and T helper type 2 cells. Eur J Immunol 1994;24:980-4.
72. Kharitonov S, Yates D, Barnes P. Increased nitric oxide in exhaled air of normal human subjects with upper respiratory tract infections. Eur Respir J 1995;8:295-7.
73. Corne J, Lau L, Scott S, Davies R, Friend E, Howarth P. Nitric oxide levels during upper respiratory tract infection. Am J Respir Crit Care Med 1996;153:A259.
74. Levandowski R, Ou D, Jackson G. Acute-phase decrease of T lymphocyte subsets in rhinovirus infection. J. Infect Dis 1986;153:743-8.
75. Levandowski R, Weaver C, Jackson G. Nasal-secretion leukocyte populations determined by flow cytometry during acute rhinovirus infection. J Med Virol 1988;25:423-32.
76. Hsia J, Goldstein A, Simon G, Sztein M, Hayden F. Peripheral blood mononuclear cell interleukin-2 and interferon-γ production, cytotoxicity, and antigen-stimulated blastogenesis during experimental rhinovirus infection. J Infect Dis 1990;162:591-7.
77. Noah T, Henderson F, Wortman I, Devlin R, Handy J, Koren H, et al. Nasal cytokine production in viral upper respiratory infection of childhood. J Infect Dis 1995;171: 584-92.
78. Ward BJ, Griffin DE. Changes in cytokine production after measles virus vaccination: predominant production of IL-4 suggests induction of a Th2 response. Clin Immunol Immunopathol 1993;67:171-7.
79. Ramsay AJ, Ruby J, Ramshaw IA. A case for cytokines as effector molecules in the resolution of virus infection. Immunol Today 1993;14:155-7.
80. Morris A, Lin Y, Askonas B. Immune interferon release when a cloned cytotoxic T-cell line meets its correct influenza infected target cell. Nature 1982;295:150-2.
81. Ruby J, Ramshaw I. The anti-viral activity of immune CD8+ T cells is dependent on IFNγ. Lymphokine Cytokine Res 1991;10:353-8.
82. Baumgarth N, Brown L, Jackson D, Kelso A. Novel features of the respiratory tract T-cell response to influenza virus infection: lung T cells increase expression of gamma interferon mRNA in vivo and maintain high levels of mRNA expression for interleukin-5 and interleukin-10. J Virol 1994;68:7575-81.
83. Erard F, Wild M-T, Garcia-Sanz J, Le Gros G. Switch of CD8 T cells to noncytolytic CD8-CD4- cells that make Th2 cytokines and help B cells. Science 1993;260:1802-5.
84. Coyle A, Erard F, Bertrand C, Walti S, Pircher H, LeGros G. Virus specific CD8 cells can switch to IL-5 production and induce airway eosinophilia. J Exp Med 1995;181: 1229-33.
85. Alwan W, Kozlowska W, Openshaw P. Distinct types of lung disease caused by functional subsets of antiviral T cells. J Exp Med 1994;179:81-9.
86. Yewdell J, Bennink J, Hosaka Y. Cells process exogenous proteins for recognition by cytotoxic T lymphocytes. Science 1988;239:637-40.
87. Promwong C, Stanciu L, Corne J, Holgate S, Djukanovic R. T lymphocyte responsiveness to house dust mite in atopic asthmatic patients with respiratory tract viral infections. Am J Respir Crit Care Med 1995;151:A215.
88. Kamp S, Kreff B, Braun J, Dalhaff K. A rapid semi automatic enzyme linked immunoassay identifying intercellular adhesion molecule-1 (ICAM-1) on the alveolar macrophage surface. Eur J Clin Chem Clin Biochem 1994; 32:455.
89. Peschke T, Bender A, Nain M, Gemsa D. Role of macrophage cytokines in influenza A virus infections. Immunobiology 1993;189:340-55.
90. Bender A, Amann U, Jager R, Nain M, Gemsa D. Effect of granulocyte macrophage colony-stimulating factor on human monocytes infected with influenza A virus. Enhancement of virus replication, cytokine release, and cytotoxicity. J Immunol 1993;151:5416-24.
91. Vrtis R, Dick E, Gern J, Busse W. The effect of rhinovirus (RV) 16 on mononuclear cell generation of α and γ interferon (IFN). J Allergy Clin Immunol 1996;97:283.
92. Gern J, Dick E, Lee W, Murray S, Meyer K, Handzel Z, et al. Rhinovirus enters but does not replicate inside monocytes and airway macrophages. J Immunol 1996; 156:621-7.
93. Schandene L, Franco G, Prete F, Cogan E, Stordeur P, Crusiaux A, et al. Recombinant interferon-alpha selectively inhibits the production of interleukin-5 by human CD4+ T cells. J Clin Invest 1996;97:309-15.
94. Panuska J, Merolla R, Rebert N, Hoffmann S, Tsiuitse P, Cirino N, et al. Respiratory syncytial virus induces interleukin-10 by human alveolar macrophages. Suppression of early cytokine production and implications for incomplete immunity. J Clin Invest 1995;96:2445-53.
95. Saranar S, Doherty P. Concurrent production of interleukin-2, interleukin-10 and gamma interferon in the regional lymph nodes of mice with influenza pneumonia. J Virol 1994;68:3112-8.
96. Del Prete G, DeCarli M, Almerigogna F, Giudizi M, Biagiotti R, Romagnani S. Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J Immunol 1993;150:353-60.
97. Clementson P, Kristenson KS, Norn S. Virus, bacteria and lipopolysacharide increase basophil cell response to histamine releasing stimulators and calcium. Allergy 1991; 46:135-41.
98. Sanchez-Legrand F, Smith TF. Interaction of paromyxovirus with human basophils and their effect on histamine release. J Allergy Clin Immunol 1989;84:538-46.
99. Thomas L, Bardin P, Fraenkel D, Holgate S, Warner J. Infection with human rhinovirus (HRV) increases priming by α or γ interferon (IFN) in human basophils. J Allergy Clin Immunol 1993;93:197.
100. Thomas L, Corne J, Holgate S, Warner J. Integrin clustering causes increased histamine release (HR) form basophils of patients with symptomatic colds. FASEB J 1995;9:A1046.
101. Ida S, Hooks JJ, Siraganian RP, Notkins AL. Enhancement of IgE mediated histamine release from human basophils by viruses: role of interferon. J Exp Med 1977;145:892-906.
102. Smith TF, Remingo LK. Histamine in nasal secretions may be elevated during viral respiratory tract infections. Int Arch Allergy Appl Immunol 1982;67:380.
103. Igarashi Y, Skoner D, Doyle W, White M, Fireman P, Kaliner M. Analysis of nasal secretions during experimental rhinovirus upper respiratory tract infection. J Allergy Clin Immunol 1993:92:722-31.
104. Proud D, Naclerio R, Gwaltney J, Hendley J. Kinins are generated in nasal secretions during natural rhinovirus colds. J Infect Dis 1990;161:120-3.
105. Ogunbiyi P, Black W, Eyre P. Parainfluenza 3 virus-induced enhancement of histamine release from calf lung mast cells; effect of levamisole. J Vet Pharmacol Ther 1988;11: 338-44.
106. Sorden S, Castleman W. Virus-induced increases in airway mast cells in brown Norway rats are associated with enhanced pulmonary viral replication and persisting lymphocytic infiltration. Exp Lung Res 1995;21:197-213.
107. Herxheimer H, Stresemann E. The effect of bradykinin aerosol in guinea-pigs and in man. J Physiol 1961;158: 38-9P.
108. 2 receptor. Am Rev Respir Dis 1990; 142:1104-7.
109. Baraniuk J, Lundgren J, Mizogwhi H, Peden D, Gawin A, Merida A, et al. Bradykinin and respiratory mucous membranes. Analysis of bradykinin binding sites distribution and secretory responses in vitro and in vivo. Am Rev Respir Dis 1990;141:706-14.
110. Naclerio R, Proud D, Lichtenstein L, Kagey-Sobotka A, Hendley J, Sorrentino J, et al. Kinins are generated during experimental rhinovirus colds. J Infect Dis 1987;157:133-42.
111. Skoner D, Shibayama Y, Doyle W, Seroky J, Fireman P, Cohen S, et al. Effect of experimental rhinovirus (RV-39) infection on nasal bradykinin (BK) levels. J Allergy Clin Immunol 1996;97:306.
112. Frick OL, German DF, Mills J. Development of allergy in children: association with virus infection. J Allergy Clin Immunol 1979;64:228-41.
113. Bahna SL, Horwitz CA, Fiala M, Heiner DL. IgE response in heterophil-positive infectious mononucleosis. J Allergy Clin Immunol 1978;62:167-73.
114. Griffin DE, Cooper SJ, Hirsch RC, Johnson RJ, Lindo de Soriano I, Roedenbeck S, et al. Changes in plasma IgE levels during complicated and uncomplicated measles virus infections. J Allergy Clin Immunol 1985;76:206-13.
115. Michaels AA, Stevens MB, Adkinson Jr NF. Detection of influenza vaccine specific IgE. J Allergy Clin Immunol 1979;63:169.
116. Perelmutter L, Potvin L, Phipps P. Immunoglobulin E response during viral infections. J Allergy Clin Immunol 1979;64:127-30.
117. Skoner D, Doyle W, Tanner E, Kiss J, Fireman P. Effect of rhinovirus 39 (RV-39) infection on immune and inflammatory parameters in allergic and non-allergic subjects. Clin Exp Allergy 1995;25:561-7.
118. Lin C, Kuo W, Lin W, Lin C. Immunomodulation of influenza virus infection in the precipitating asthma attack. Chest 1988;93:1234-8.
119. Welliver RC, Wong DT, Sun M, Middleton Jr E, Vaughan RS, Ogra PL. The development of respiratory syncitial virus-specific IgE and the release of histamine in nasopharyngeal secretions after infection. N Engl J Med 1981; 305:841-6.
120. Welliver R, Wong D, Middleton E, Sun M, McCarthy N, Ogra P. Role of parainfluenza virus-specific IgE in pathogenesis of croup and wheezing subsequent to infection. J Pediatr 1982;101:889-96.
121. Tipirneni P, Moore B, Hyde J, Schauf V. IgE antibodies to Mycoplasma pneumoniae in asthma and other atopic diseases. Ann Allergy 1980;45:1-7.
122. Macek V, Sorli J, Kopriva S, Marin J. Persistent adenoviral infection and chronic airway obstruction in children. Am J Respir Crit Care Med 1994;150:7-10.
123. McFadden E, Denison D, Waller J, Assonfi B, Peacock A, Sopwith T. Direct recordings of the temperatures in the tracheobronchial tree in normal man. J Clin Invest 1982; 69:700-5.
124. Craighead J, Meier M, Cooley M. Pulmonary infection due to rhinovirus type 13. N Engl J Med 1969;281: 1403-4.
125. Heras J, Swanson V. Sudden death of an infant with rhinovirus infection complicating bronchial asthma: a case report. Pediatr Pathol 1983;1:319-23.
126. Horn MEC, Reed SA, Taylor P. Role of viruses and bacteria in acute wheezy bronchitis in childhood: a study of sputum. Arch Dis Child 1979;54:587-92.
127. Halperin S, Eggleston P, Hendley J, Suratt P, Hendley J, Grocschel D, et al. Exacerbations of asthma in adults during experimental rhinovirus infection. Am Rev Respir Dis 1985;132:976-80.
128. Gern J, Galagan D, Jarjour N, Kelly E, Busse W. Detection of rhinovirus 16 (RV16) in the lower airway of experimentally-infected subjects. J Allergy Clin Immunol 1996;97:353.
129. Bardin P, Johnston S, Sanderson G, Robinson S, Pickett M, Fraenkel D, et al. Detection of rhinovirus infection of the nasal mucosa by oligonucleotide in situ hybridisation. Am J Respir Cell Mol Biol 1994;10:207-13.